BRS Sizing and Vessel Preparation

Slides:



Advertisements
Similar presentations
TAVOLA ROTONDA Quale Ruolo Clinico e Quale Rimborso per la Franctional Flow Reserve? Correlazioni anatomo-funzionali FFR vs IVUS Luigi Vignali, Parma Bologna.
Advertisements

TCT 2012 Revascularization Strategies for Complex Left Main Disease and Left Coronary Ostial Disease Alfredo E. Rodriguez, MD, PhD, FACC, FSCAI Centro.
左主干分叉病变治疗策略的选择 Left main bifurcation: what is the best choice? Lei Ge, MD Department of Cardiology, Zhongshan Hospital, Fudan University.
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki.
Saqib Chowdhary Wythenshawe Hospital STENT THROMBOSIS How Do IVUS & OCT Help.
Columbia University Medical Center Cardiovascular Research Foundation New York City, NY Akiko Maehara, MD Use of IVUS Reduces Stent Thrombosis and Myocardial.
Philippe Généreux, MD for the Tryton Bifurcation Trial Investigators Columbia University Medical Center Cardiovascular Research Foundation New York City.
Lessons from PARTNER I (A & B) CRT, Washington DC, Feb 5, 2012
Intravascular ultrasound (IVUS) in percutaneous coronary intervention – summary of key articles While angiography is routinely used for assessment of CAD,
Intravascular ultrasound (IVUS) in the treatment of long and diffuse lesions– summary of key articles Prepared by Radcliffe Cardiology 21 November2016.
Disclosure Statement of Financial Interest
Abdominal Aortic Aneurysm Repair Hugo Londero Sanatorio Allende Córdoba - Argentina.
De Novo and Restenotic Coronary Lesions
Disclosure Statement of Financial Interest
Valvuloplasty Scoring Balloon for the Treatment of Critical Aortic Valve Stenosis - Design of a FIM Study - Gary Gershony, MD, FACC, FSCAI, FAHA, FRCPC.
Everolimus-eluting Bioresorbable Vascular Scaffolds in Patients with Coronary Artery Disease: ABSORB III Trial 2-Year Results Stephen G. Ellis, MD,
Disclosure Statement of Financial Interest
Ospedale San Raffaele, Milan, Italy
Disclosure Statement of Financial Interest
Ajay J. Kirtane, MD I have no real or apparent conflicts of interest to report.
Physiologic Lesion Assessment: Advantages and Pitfalls
on behalf of the ABSORB II Investigators
How to Build A Successful Clinical Research Program
Advanced CTO Techniques:
RevElution Clinical Trial
Non-Inferiority Exposed: Uses and Abuses
Impact of Technique on Early and Late Outcomes Following Coronary Bioresorbable Scaffold Implantation: Analysis from the ABSORB trials.
Novel atherectomy devices for the coronary calcified lesions
DES Malapposition and How It Correlates to DES Thrombosis
(DES)+BVS +DCB for long diffuse LAD disease
On behalf of the PRECOMBAT Investigators
Washington Hospital Center, Division of Cardiology
Columbia University Medical Center Cardiovascular Research Foundation
Gregg W. Stone, MD Columbia University Medical Center
Craig A. Thompson, M.D., MMSc.
DKCRUSH V Shao-Liang Chen, MD DKCRUSH V
The DKCRUSH-V Randomized Trial
Comprehensive Meta-Analysis of DES vs
Crossing CTOs via Planned Dissection: LaST (Limited Antegrade Subintimal Tracking): from knuckle wire to Bridgepoint Craig A. Thompson, M.D., MMSc. Director,
BRS Summit – Scaffold Fractures
BVS Expand: First Results of Wide Clinical Applications
Overview of the Clinical Utility of IVUS to Optimize PCI
Elixir Medical Novolimus Elution from A Biodegradable Polymer
EXCELLA Studies - Novolimus Elution from PLLA Polymer Coated Stents DESyne® and DESyne BD: Design Specifications and Clinical Updates Stefan Verheye,
Crossing CTOs via Planned Dissection: LaST (Limited Antegrade Subintimal Tracking): from knuckle wire to Bridgepoint Craig A. Thompson, M.D., MMSc. Director,
OCT-Guided PCI What needs to be done to establish criteria?
Collagenase for CTO: An update Bradley H
6-Month Imaging and 1 year Clinical and MSCT Results
Thomas Stiermaier, MD; Suzanne de Waha, MD;
Three Years Follow Up. SORT OUT II
Early strut coverage in patients receiving new-generation drug-eluting stents and its implications for dual antiplatelet therapy: a randomized clinical.
Predictors of Acute, Subacute and Late Stent Thrombosis After Acute MI Primary Angioplasty in the Horizons AMI Trial George D. Dangas, Alexandra J. Lansky,
Impact of calcium on procedural and clinical outcomes in lesions treated with bioresorbable vascular scaffolds - A prospective BRS registry study  Jiang.
CIT 2018 Template Title 40 pt Bold Arial
CIT 2018 Template Title 40 pt Bold Arial
CIT 2017 Template Title 40 pt Bold Arial
Comparison of Everolimus- and Biolimus-Eluting Coronary Stents With Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-year Outcomes of the EVERBIO.
Five-Year Cumulative Rates of Clinical Events after Cypher™ Stent Implantation: Insights from a Patient-Level Pooled Analysis of Four Randomized Trials.
CIT 2018 Template Title 40 pt Bold Arial
CIT 2017 Template Title 40 pt Bold Arial
CIT 2017 Template Title 40 pt Bold Arial
TAXUS – Myonecrosis and sidebranch patency concerns are short-term issues with no long-term consequences, and the benefits are undeniable Jeffrey J. Popma,
12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs. metallic drug-eluting.
Division of Endovascular Interventions
Comprehensive Meta-Analysis of DES vs
CIT 2017 Template Title 40 pt Bold Arial
Gregg W. Stone, MD Columbia University Medical Center
Impact of Diabetes Mellitus on Long-term Outcomes in the
Title 40pt Trebuchet MS Bold
CIT 2018 Template Title 40 pt Bold Arial
Presentation transcript:

BRS Sizing and Vessel Preparation BRS Technologies: Technology & Innovation BRS for Clinical Use, Implantation Technique and Patient Selection BRS Sizing and Vessel Preparation Ricardo A. Costa, MD, PhD Institute Dante Pazzanese, Sao Paulo, Brazil Sunday, Feb. 19th 2017 – 11:08 to 11:15 am (7 minutes) Room Congressional AB – The Omni Shoreham Hotel Washington, DC, USA

Conflict of Interest Statement Ricardo A. Costa, MD, PhD   I have no relevant financial relationships to disclose

BRS Issues Associated with Vessel Sizing Thick struts (~150 microns) Limited size range Rectangular/square shape Limited overexpansion capability Impact on flow dynamics Suboptimal expansion Need to full embedment and apposition

Lipinski et al. JACC Cardiovasc Interv 2016;9(1):12-24 Increased Risk of ST with 1st Generation BVS compared to 2nd Generation EES Lipinski et al. JACC Cardiovasc Interv 2016;9(1):12-24

Increased Risk of Very Late ST in ABSORB II Serruys et al. Lancet 2016;http://dx.doi.org/10.1016/S0140-6736(16)32050-5

Meta-Analysis: 16,830 pts in 59 Studies Variable Coefficient 95% CI P value Univariate Model Dyslipidemia -0.0127 -0.0238 to -0.0016 0.03 Diabetes mellitus -0.0285 -0.0537 to -0.0033 Vessel size (RVD) -1.0520 -1.9467 to -0.1573 0.02 Residual % DS 0.0673 0.0272 to 0.1075 <0.0001 Residual stenosis (%) 0.001 Multivariate Model 0.091 -0.00009 to 0.1832 0.052 Collet et al. Minerva Cardioangiol 2016:published online

Inaccuracy of Visual Estimation of Vessel Size NC 3.5 x 12 (20 atm) 3.25 x 18 mm Scaffold (After pre-dil w/ 3.0x15 NC Balloon) Pre-PCI Angio Control Angio This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and we’ll adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in the lower left hand part of your screen to return to the slide show. (Small white rectangle) Courtesy: Daniel Chamié, MD, Brazil 7

Inaccuracy of Visual Estimation of Vessel Size Control Angio After 3.25x18 mm PLLA-based scaffold post-dilated to > 3.5 mm 3.25x18 mm scaffold This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and we’ll adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in the lower left hand part of your screen to return to the slide show. (Small white rectangle) 8

Inaccuracy of Visual Estimation of Vessel Size B 3 2 1 A A 1 2 3 B This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and we’ll adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in the lower left hand part of your screen to return to the slide show. (Small white rectangle) Lumen Area: 12.43 mm2 Max. Diam.: 4.13 mm Lumen Area: 7.42 mm2 Max. Diam.: 3.23 mm 9

Farooq V, et al. Cathet Cardiovasc Interv. 2012;79:880-888

Inaccuracy of Visual Estimation of Vessel Size Quantification by QCA of vessels treated with 3.0-mm scaffolds in ABSORB Cohort B (n=102) (visual estimation of vessel size) 56.9% 47.1% 40.2% 39.2% 16.7% This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and we’ll adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in the lower left hand part of your screen to return to the slide show. (Small white rectangle) 2.9% Inadequately sized scaffolds Adequate reference size range for a 3.0 Absorb Inadequately sized scaffolds Farooq V, et al. Cathet Cardiovasc Interv. 2012;79:880-888 11

QCA: Interpolated Diameter vs. Max. Diameter Quantification by QCA of vessels treated with 3.0-mm scaffolds in ABSORB Cohort B (visual estimation of vessel size) and in ABSORB EXTEND (QCA mandated - DMAX) P=0.001 69.4% P=0.057 56.9% 57.0% 47.1% P=0.002 40.2% 41.1% 39.2% 26.9% 16.7% This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and we’ll adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in the lower left hand part of your screen to return to the slide show. (Small white rectangle) 2.9% 3.7% 1.9% ABSORB Cohort B (n=102) ABSORB EXTEND (n=108)a (n=107)b a n=108 for Dmax assessment b n=107 for interp. diam. assessment Farooq V, et al. Cathet Cardiovasc Interv. 2012;79:880-888 12

QCA vs. IVUS vs. OCT 100 CAD patients from 5 centers were studied with Angio, IVUS and FD-OCT 5 Phantom models, with known luminal dimensions were examined with FD-OCT and IVUS Differences in MLD among Angio, IVUS and FD-OCT Differences in Lumen Area between IVUS and FD-OCT This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and we’ll adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in the lower left hand part of your screen to return to the slide show. (Small white rectangle) Kubo T, et al. JACC Cardiovasc Imaging 2013;6:1095-1104 13

Intravascular Imaging: Vessel Diameter Sizing Maximum diameter of the smaller reference. Average of the maximum diameters of the prox. and distal references. Maximum diameter of the largest reference. Mid-wall to mid-wall diameters (between lumen and media) Media-to-media diameter 2 Increasingly Aggressive 1 2 1 2 1 This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and we’ll adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in the lower left hand part of your screen to return to the slide show. (Small white rectangle) Max. LD: 4.01 mm Mean Mid-wall diam.: 4.18 mm Mean EEM diam: 4.28 mm Max. LD: 3.09 mm Mean Mid-wall diam.: 3.14 mm Mean EEM diam: 3.26 mm Max. LD: 3.96 mm Mean Mid-wall diam.: 4.02 mm Mean EEM diam: 4.19 mm Max. LD: 3.00 mm Mean Mid-wall diam.: 3.09 mm Mean EEM diam: 3.19 mm 14

Integrating Concepts This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and we’ll adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in the lower left hand part of your screen to return to the slide show. (Small white rectangle) 15

Intended landing zones Integrating Concepts 6F guide 3.5 x 20 mm NC balloon Intended landing zones This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and we’ll adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in the lower left hand part of your screen to return to the slide show. (Small white rectangle) 16

Step back and rethink your strategy Integrating Concepts A B C C B A LA: 8.68 mm2 Max. LD: 3.56 mm Mean EEM: 4.00 LA: 7.25 mm2 Max. LD: 3.04 mm LA: 11.58 mm2 Max. LD: 4.18 mm Mean EEM: 4.46 mm This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and we’ll adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in the lower left hand part of your screen to return to the slide show. (Small white rectangle) Step back and rethink your strategy 17

Post-dil w/ 4.5/15 NC balloon Integrating Concepts 4.0x30 mm DES Post-dil w/ 4.5/15 NC balloon This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and we’ll adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in the lower left hand part of your screen to return to the slide show. (Small white rectangle) 18

Take Advantage of the Inflated Balloon Acquire a proper angiogram after IC nitro administration; Pre-dilate the lesion with a NC balloon sized 1:1 to the target vessel size at the intended landing zones NC Balloon 3.0 x 15 mm NC Balloon 3.0 x 15 mm This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and we’ll adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in the lower left hand part of your screen to return to the slide show. (Small white rectangle) 19

Puricel et al. J Am Coll Cardiol 2016;67(8):921-31 Impact of Optimal Implantation Technique on the Reduction of the Risk of ST 1) pre-dilatation with NC balloon – same size as RVD (1:1) 2) BVS implant only if optimal result achieved 3) BVS same size as RVD implanted at 10-12 atm 4) Systematic postdilatation with NC balloon up to 0.5 mm larger with 14-16 atm Puricel et al. J Am Coll Cardiol 2016;67(8):921-31

Tanaka et al. EuroIntervention 2016;published online Milan Series: 264 pts Treated with BVS with Optimal Technique – FU @ 2 Yrs 400 complex lesions (B2/C >70%) Bifurcation 47%, Heavy calcium 23%, CTO 6%, ISR 5% Mean scaffold length: 53.2 mm 44% received scaffold sized 2.5 mm IVUS/OCT in 86% (AVIO criteria) Additional treatment in 25% due to: Underexpansion in 82 Malapposition in 11 Edge dissection in 4 Incomplete lesion coverage in 1 ST: 3 cases (1.2%) up to 2 years (no very late ST) Tanaka et al. EuroIntervention 2016;published online

Impact of OCT-Guided PCI

Baseline Lesion Characteristics Variable BVS (n=50) DES (n=50) P value LAD 68% 50% 0.11 Type C lesion (ACC/AHA) 64% 74% 0.38 Significant calcium 62% 0.28 Ostial location 14% 10% 0.76 Bifurcation 34% 46% 0.30 ISR 12% 6% 0.48 QCA Lesion length, mm 24.7 25.1 0.86 RD, mm 2.7 MLD, mm 0.8 0.7 0.16 AS, % 83.7 86.9 0.25 Mattesini et al. JACC Cardiovasc Interv 2014;7(7):741-50

Mattesini et al. JACC Cardiovasc Interv 2014;7(7):741-50 Procedure Variable BVS (n=50) DES (n=50) P value Balloon predilatation - Maximal diameter, mm 3.0 2.5 <0.01 - Maximal pressure, atm 18.7 15.1 - Balloon/artery ratio 1.1 0.9 - Balloon type: NC 100% 87% Scaffolds/Stents 63 61 - - Nominal diameter, mm 0.94 - Nominal length, mm 28.0 0.42 - Devices per lesion 1.3 1.2 0.28 Balloon postdilatation 3.5 0.60 21.3 17.1 Mattesini et al. JACC Cardiovasc Interv 2014;7(7):741-50

Mattesini et al. JACC Cardiovasc Interv 2014;7(7):741-50 OCT Findings Variable BVS (n=50) DES (n=50) P value Mean device area, mm2 7.3 7.5 0.51 Minimal stent area, mm2 5.9 5.5 0.67 Mean lumen area, mm2 7.2 7.4 0.40 Minimal lumen area, mm2 5.8 0.97 Minimal device diameter, mm 2.7 2.8 0.46 Residual area stenosis, % 20.2 21.7 0.32 - >20% 39.7 42.6 0.85 Eccentricity index 0.86 0.45 ISA (per struts), % 1.7 1.9 0.62 Prolapse area, mm2 1.5 0.8 0.08 Fracture, % 3.2 0.49 Edge dissection, % 7.9 11.5 0.55 Mattesini et al. JACC Cardiovasc Interv 2014;7(7):741-50

Chamie et al. Catheter Cardiovasc Interv. 2016;88(S1):38-53 How to Size the Vessel? Chamie et al. Catheter Cardiovasc Interv. 2016;88(S1):38-53

Proposed Algorithm

Considerations Visual estimation is the standard method of vessel sizing, but it is subject to high variability and inaccuracy. QCA (DMAX) helps standardize measurements, but it underestimates lumen diameters in comparison to intravascular imaging methods. NC compliant balloon fully expanded at 1:1 ratio to the target landing zones is extremely helpful. Intravascular imaging (IVUS/OCT) is not mandatory, but lower threshold for use is highly recommended. OCT provides more accurate lumen quantification than IVUS. Specific protocol for sizing with IVUS/OCT for BRS still needs validation. Careful lesion predilatation under the PSP guidance may significantly improve outcomes. This is the Bulleted List slide. To create this particular slide, click the NEW SLIDE button on your toolbar and choose the BULLETED LIST format. (Top row, second from left) The Sub-Heading and footnote will not appear when you insert a new slide. If you need either one, copy and paste it from the sample slide. If you choose not to use a Sub-Heading, let us know when you hand in your presentation for clean-up and we’ll adjust where the bullets begin on your master page. Also, be sure to insert the presentation title onto the BULLETED LIST MASTER as follows: Choose View / Master / Slide Master from your menu. Select the text at the bottom of the slide and type in a short version of your presentation title. Click the SLIDE VIEW button in the lower left hand part of your screen to return to the slide show. (Small white rectangle) 32

Thanks for your attention!